A. Tolcher: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Case report and summary of literature: giant perineal keloids treated with post-excisional radiotherapy

Kristin Jones, Clifton D Fuller, Join Y Luh, Craig C Childs, Alexander R Miller, Anthony W Tolcher, Terence S Herman, Charles R Thomas

Journal:

BMC Dermatology

Year:

2006

Language:

english

File:

PDF, 1.01 MB

english, 2006

2

A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors

Weekes, Colin D., Beeram, Muralidhar, Tolcher, Anthony W., Papadopoulos, Kyriakos P., Gore, Lia, Hegde, Priti, Xin, Yan, Yu, Ron, Shih, L. Mason, Xiang, Hong, Brachmann, Rainer K., Patnaik, Amita

Journal:

Investigational New Drugs

Year:

2014

Language:

english

File:

PDF, 387 KB

english, 2014

3

A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody–drug conjugate, in patients with breast cancer and other advanced solid tumors

Rosen, Lee S., Wesolowski, Robert, Baffa, Raffaele, Liao, Kai-Hsin, Hua, Steven Y., Gibson, Brenda L., Pirie-Shepherd, Steven, Tolcher, Anthony W.

Journal:

Investigational New Drugs

Year:

2019

Language:

english

File:

PDF, 326 KB

english, 2019

4

Acute arterial thrombosis in a patient with breast cancer after chemotherapy with 5-fluorouracil, doxorubicin, leucovorin, cyclophosphamide, and interleukin-3

C. Theodossiou, G. Kroog, S. Ettinghausen, A. Tolcher, K. Cowan, J. O'Shaughnessy

Journal:

Year:

1994

Language:

english

File:

PDF, 283 KB

english, 1994

5

Preferred noise levels whilst carrying out mental tasks

M.E. Bryan, D. Tolcher

Journal:

Journal of Sound and Vibration

Year:

1976

Language:

english

File:

PDF, 1.62 MB

english, 1976

6

Novel apoptosis inducing agents in cancer therapy

Monica Mita, Anthony W. Tolcher

Journal:

Current Problems in Cancer

Year:

2005

Language:

english

File:

PDF, 290 KB

english, 2005

7

Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA

Zuckerman, J. E., Gritli, I., Tolcher, A., Heidel, J. D., Lim, D., Morgan, R., Chmielowski, B., Ribas, A., Davis, M. E., Yen, Y.

Journal:

Proceedings of the National Academy of Sciences

Year:

2014

Language:

english

File:

PDF, 991 KB

english, 2014

8

Phase I Safety, Pharmacokinetic and Pharmacodynamic Evaluation of the Vascular Disrupting Agent Ombrabulin (AVE8062) in Patients with Advanced Solid Tumors

Sessa, C., Lorusso, P., Tolcher, A., Farace, F., Lassau, N., Delmonte, A., Braghetti, A., Bahleda, R., Cohen, P., Hospitel, M., Veyrat-Follet, C., Soria, J.-C.

Journal:

Clinical Cancer Research

Year:

2013

Language:

english

File:

PDF, 368 KB

english, 2013

9

Phase I First-in-Human Study of CUDC-101, a Multitargeted Inhibitor of HDACs, EGFR, and HER2 in Patients with Advanced Solid Tumors

Shimizu, T., LoRusso, P. M., Papadopoulos, K. P., Patnaik, A., Beeram, M., Smith, L. S., Rasco, D. W., Mays, T. A., Chambers, G., Ma, A., Wang, J., Laliberte, R., Voi, M., Tolcher, A. W.

Journal:

Clinical Cancer Research

Year:

2014

Language:

english

File:

PDF, 595 KB

english, 2014

10

Phase I and Pharmacokinetic Study of Pemetrexed with High-Dose Folic Acid Supplementation or Multivitamin Supplementation in Patients with Locally Advanced or Metastatic Cancer

Takimoto, C. H., Hammond-Thelin, L. A., Latz, J. E., Forero, L., Beeram, M., Forouzesh, B., de Bono, J., Tolcher, A. W., Patnaik, A., Monroe, P., Wood, L., Schneck, K. B., Clark, R., Rowinsky, E. K.

Journal:

Clinical Cancer Research

Year:

2007

Language:

english

File:

PDF, 359 KB

english, 2007

11

Risk Factors for Postpartum Hemorrhage Following Nulliparous Induction of Labor [3C]

Ainsworth, Alessandra J., Holman, Michelle A., McGree, Michaela, Weaver, Amy, Torbenson, Vanessa, Tolcher, Mary Catherine

Journal:

Obstetrics & Gynecology

Year:

2017

Language:

english

File:

PDF, 75 KB

english, 2017

12

952: Low-dose aspirin (ASA) for preeclampsia prevention among high-risk women by ethnicity and race

Tolcher, Mary C., Sangi-Haghpeykar, Haleh, Aagaard, Kjersti M.

Journal:

American Journal of Obstetrics and Gynecology

Year:

2018

Language:

english

File:

PDF, 629 KB

english, 2018

13

Intrapartum factors associated with neonatal hypoxic ischemic encephalopathy: a case-controlled study

Torbenson, Vanessa E., Tolcher, Mary Catherine, Nesbitt, Kate M., Colby, Christopher E., EL-Nashar, Sherif A., Gostout, Bobbie S., Weaver, Amy L., Mc Gree, Michaela E., Famuyide, Abimbola O.

Journal:

BMC Pregnancy and Childbirth

Year:

2017

Language:

english

File:

PDF, 380 KB

english, 2017

14

326: Risk factors for maternal morbidity following nulliparous induction at term

Tolcher, Mary C., Sangi-Haghpeykar, Haleh, Clark, Steven L.

Journal:

American Journal of Obstetrics and Gynecology

Year:

2018

Language:

english

File:

PDF, 638 KB

english, 2018

15

A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors

Smith, David C., Chugh, Rashmi, Patnaik, Amita, Papadopoulos, Kyriakos P., Wang, Min, Kapoun, Ann M., Xu, Lu, Dupont, Jakob, Stagg, Robert J., Tolcher, Anthony

Journal:

Investigational New Drugs

Year:

2018

Language:

english

File:

PDF, 1.50 MB

english, 2018

16

Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies

Hidalgo, Manuel, Siu, Lillian L., Nemunaitis, John, Rizzo, Jinee, Hammond, Lisa A., Takimoto, Chris, Eckhardt, S. Gail, Tolcher, Anthony, Britten, Carolyn D., Denis, Louis, Ferrante, Karen, Von Hoff,

Journal:

Journal of Clinical Oncology

Year:

2001

File:

PDF, 720 KB

2001

17

Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model

Simon Leung, Hideaki Miyake, Tobias Zellweger, Anthony Tolcher, Martin E. Gleave

Journal:

International Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 111 KB

english, 2001

18

A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer

Stacy L. Moulder, Frankie A. Holmes, Anthony W. Tolcher, Peter Thall, Kristine Broglio, Vicente Valero, Aman U. Buzdar, Susan G. Arbuck, Andrew Seidman, Gabriel N. Hortobagyi

Journal:

Year:

2010

Language:

english

File:

PDF, 168 KB

english, 2010

19

PI-13Pharmacokinetics and pharmacodynamics of a HER2 tyrosine kinase inhibitor CP-724714 in patients with advanced malignant HER2 positive solid tumors

GUO, F, LETRENT, S, NOE, D, QIN, A, ROHRBACHER, K, MUNSTER, P, TOLCHER, A, BRITTEN, C, GELMON, K, SHARMA, A

Journal:

Clinical Pharmacology & Therapeutics

Year:

2006

Language:

english

File:

PDF, 48 KB

english, 2006

20

Validation of a high-performance liquid chromatographic assay method for quantification of total vincristine sulfate in human plasma following administration of vincristine sulfate liposome injection

Leanne Embree, Karen A. Gelmon, Anthonly W. Tolcher, Norma J. Hudon, Jean R. Heggie, Carole Dedhar, Murry S. Webb, Marcel B. Bally, Lawrence D. Mayer

Journal:

Journal of Pharmaceutical and Biomedical Analysis

Year:

1997

Language:

english

File:

PDF, 121 KB

english, 1997

21

In vitro sensitivity testing of human breast cancer cells to hormones and chemotherapeutic agents

J. T. Emerman, A. W. Tolcher, P. M. Rebbeck

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1990

Language:

english

File:

PDF, 469 KB

english, 1990

22

A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma

Monica M. Mita, Eric K. Rowinsky, Leonardo Forero, S. Gail Eckhart, Elzbieta Izbicka, Geoffrey R. Weiss, Muralidhar Beeram, Alain C. Mita, Johann S. de Bono, Anthony W. Tolcher, Lisa A. Hammond, Paul

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2007

Language:

english

File:

PDF, 353 KB

english, 2007

23

Pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors: correlations with clinical characteristics and safety

Feng Guo, Stephen P. Letrent, Pamela N. Munster, Carolyn D. Britten, Karen Gelmon, Anthony W. Tolcher, Amarnath Sharma

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2008

Language:

english

File:

PDF, 382 KB

english, 2008

24

Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study

Jordi Rodon, Mitchell Garrison, Lisa A. Hammond, Johann de Bono, Lon Smith, Leonardo Forero, Desirée Hao, Chris Takimoto, John M. Lambert, Lini Pandite, Maria Howard, Hongsheng Xie, Anthony W. Tolcher

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2008

Language:

english

File:

PDF, 377 KB

english, 2008

25

Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28

Chia-Chi Lin, Muralidhar Beeram, Eric K. Rowinsky, Chris H. Takimoto, Chee M. Ng, Charles E. Geyer, Louis J. Denis, Johann S. De Bono, Desiree Hao, Anthony W. Tolcher, Sun-Young Rha, Jacques Jolivet,

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2009

Language:

english

File:

PDF, 444 KB

english, 2009

26

Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1integrin monoclonal antibody (volociximab) in cancer patients

Chee M. Ng, S. Bai, C. H. Takimoto, M. T. Tang, A. W. Tolcher

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2010

Language:

english

File:

PDF, 587 KB

english, 2010

27

A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer

Anthony W. Tolcher, Leonard J. Appleman, Geoffrey I. Shapiro, Alain C. Mita, Frank Cihon, Arthur Mazzu, Pavur R. Sundaresan

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2011

Language:

english

File:

PDF, 265 KB

english, 2011

28

Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors

Muhammad Wasif Saif, John Sarantopoulos, Amita Patnaik, Anthony W. Tolcher, Chris Takimoto, Murali Beeram

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2011

Language:

english

File:

PDF, 224 KB

english, 2011

29

Pharmacokinetic behavior of vincristine sulfate following administration of vincristine sulfate liposome injection

Leanne Embree, Karen Gelmon, Anthony Tolcher, Norma Hudon, Jean Heggie, Carole Dedhar, Patricia Logan, Marcel B. Bally, Lawrence D. Mayer

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1998

Language:

english

File:

PDF, 314 KB

english, 1998

30

Apoptosis: mechanisms and implications for cancer therapeutics

Monica M. Mita, Alain C. Mita, Anthony W. Tolcher

Journal:

Targeted Oncology

Year:

2006

Language:

english

File:

PDF, 432 KB

english, 2006

31

The role of mTOR inhibitors for treatment of sarcomas

Monica M. Mita, Anthony W. Tolcher

Journal:

Current Oncology Reports

Year:

2007

Language:

english

File:

PDF, 273 KB

english, 2007

32

Nutrition and maternal health: What women want and can we provide it?

Shelley A. WILKINSON, Debbie TOLCHER

Journal:

Nutrition & Dietetics

Year:

2010

Language:

english

File:

PDF, 95 KB

english, 2010

33

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

Davis, Mark E., Zuckerman, Jonathan E., Choi, Chung Hang J., Seligson, David, Tolcher, Anthony, Alabi, Christopher A., Yen, Yun, Heidel, Jeremy D., Ribas, Antoni

Journal:

Year:

2010

Language:

english

File:

PDF, 793 KB

english, 2010

34

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

Tolcher, A W, Gerson, S L, Denis, L, Geyer, C, Hammond, L A, Patnaik, A, Goetz, A D, Schwartz, G, Edwards, T, Reyderman, L

Journal:

British Journal of Cancer

Year:

2003

Language:

english

File:

PDF, 204 KB

english, 2003

35

Post-chemotherapy and cytokine pretreated marrow stromal cell layers suppress hematopoiesis from normal donor CD34+ cells

Schwartz, G N, Warren, M K, Rothwell, S W, Zujewski, J, Halverson, D C, Cowan, K H, Tolcher, A, O’Shaughnessy, J, Gress, R E

Journal:

Bone Marrow Transplantation

Year:

1998

Language:

english

File:

PDF, 137 KB

english, 1998

36

Preface: New Therapeutic Strategies for Prostate Cancer: Reasons for Optimism and Reflection

Anthony W. Tolcher

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 32 KB

english, 2002

37

A phase I and pharmacokinetic study of the nonpolyglutamatable thymidylate synthase inhibitor ZD9331 plus docetaxel in patients with advanced solid malignancies

Garry H. Schwartz, Christopher B. Jones, Mitchell Garrison, Amita Patnaik, Chris Takimoto, Heather McCreery, Michael Skinner, Anthony W. Tolcher, Eric K. Rowinsky

Journal:

Investigational New Drugs

Year:

2004

Language:

english

File:

PDF, 145 KB

english, 2004

38

Effects of defined medium, fetal bovine serum, and human serum on growth and chemosensitivities of human breast cancer cells in primary culture: Inference for in vitro assays

Joanne T. Emerman, Eveline E. Fiedler, Anthony W. Tolcher, Patricia M. Rebbeck

Journal:

In Vitro Cellular & Developmental Biology - Plant

Year:

1987

Language:

english

File:

PDF, 1.37 MB

english, 1987

39

Analysis of the pharmacodynamic activity of the mTOR inhibitor ridaforolimus (AP23573, MK-8669) in a phase 1 clinical trial

Lori Berk, Monica M. Mita, Jeff Kreisberg, Camille L. Bedrosian, Anthony W. Tolcher, Tim Clackson, Victor M. Rivera

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2012

Language:

english

File:

PDF, 450 KB

english, 2012

40

The fallopian tube may represent the primary lesion in a minority of patients with uterine papillary serous carcinomas

M. Tolcher, F. Medeiros, E. Swisher, J. Felipe Lima, J. Hilderbrand, J. Donovan, W. Cliby, S. Dowdy

Journal:

Gynecologic Oncology

Year:

2012

Language:

english

File:

PDF, 166 KB

english, 2012

41

Preliminary phase I results of G3139 (bcl-2 antisense oligonucleotide) therapy in combination with docetaxel in hormone-refractory prostate cancer

Anthony W Tolcher

Journal:

Seminars in Oncology

Year:

2001

Language:

english

File:

PDF, 425 KB

english, 2001

42

Farnesyltransferase inhibitors and their potential in the treatment of breast carcinoma

Johann S de Bono, Anthony W Tolcher, Eric K Rowinsky

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 840 KB

english, 2003

43

Reagent decontamination to eliminate false-positives in Escherichia coli qPCR

Sarah S. Silkie, Matthew P. Tolcher, Kara L. Nelson

Journal:

Journal of Microbiological Methods

Year:

2008

Language:

english

File:

PDF, 323 KB

english, 2008

44

Other novel agents: Rationale and current status as chemopreventive agents

Anthony W Tolcher, Ann Kennedy, Robert J Padley, Noreen Majeed, Michael Pollak, Philip W Kantoff

Journal:

Year:

2001

Language:

english

File:

PDF, 114 KB

english, 2001

45

Targeting bcl-2 gene to delay androgen-independent progression and enhance chemosensitivity in prostate cancer using antisense bcl-2 oligodeoxynucleotides

Martin E Gleave, Hideaki Miayake, Jim Goldie, Colleen Nelson, Anthony Tolcher

Journal:

Year:

1999

Language:

english

File:

PDF, 733 KB

english, 1999

46

Extended temozolomine (TMZ) dosing schedules permit the administration of higher TMZ dose intensities and inhibit the DNA repair enzyme O6-alkylguanine DNA alkyltransferase (AGAT)

J. de Bono, L. Denis, A. Patnaik, L. Hammond, C. Geyer, S. Gerson, D. Cutler, L. Reyderman, E. Rowinsky, A. Tolcher

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 333 KB

english, 2001

47

1202 ORAL A Phase I Study of the Potent AKT Inhibitor MK-2206 in Combination With Carboplatin and Paclitaxel, Docetaxel or Erlotinib in Patients With Advanced Solid Tumours

L.R. Molife, S. Minton, J. Vitfell-Pedersen, E. Chen, D. Sullivan, L. Yan, A.M. Zernhelt, L. Siu, J.S. de Bono, A.W. Tolcher

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 64 KB

english, 2011

48

1209 POSTER ONX 0912, a Novel Oral Proteasome Inhibitor (PI), in Patients (pts) With Advanced Refractory or Recurrent Solid Tumours: a Phase 1, Open-label, Dose Escalation Study

K. Papadopoulos, D. Mendelson, A.W. Tolcher, H.A. Burris, M. Gordon, H. Wong, D. Bomba, S. Lee, H. Gillenwater, J. Infante

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 44 KB

english, 2011

49

135P A PHASE 1B DOSE ESCALATION STUDY OF MP-470 ADMINISTERED CONCURRENTLY WITH STANDARD OF CARE CHEMOTHERAPY IN PATIENTS WITH NSCLC AND SCLC

Mita, M., Tolcher, A., Gordon, M., Rosen, L., Fine, G.D., Choy, G.S., Berk, G.I., Mita, A.

Journal:

Year:

2009

Language:

english

File:

PDF, 44 KB

english, 2009

50

30 A phase I clinical trial of HGS-ETR1, an agonist monoclonal antibody to TRAIL-R1, in patients with advanced solid tumors

R.B. Cohen, N.J. Meropol, K.M. Padavic, N.L. Fox, A. Corey, M. Fleming, M. Mita, M. Hill, E.K. Rowinsky, A. Tolcher

Journal:

European Journal of Cancer Supplements

Year:

2004

Language:

english

File:

PDF, 136 KB

english, 2004

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски